Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-379, 2008. ,
DOI : 10.1200/JCO.2007.12.5906
URL : https://hal.archives-ouvertes.fr/hal-00363737
BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal Cancer, Clinical Cancer Research, vol.10, issue.1, pp.191-195, 2004. ,
DOI : 10.1158/1078-0432.CCR-1118-3
BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation, Science Signaling, vol.3, issue.149, p.84, 2010. ,
DOI : 10.1126/scisignal.2001148
BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer, PLoS Currents, vol.2, p.1187, 2010. ,
DOI : 10.1371/currents.RRN1187
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients, Oncology, vol.46, issue.5, pp.318-322, 1989. ,
DOI : 10.1159/000226740
Circulating tumour markers can define patients with normal colons, benign polyps and cancers, British Journal of Cancer, vol.53, issue.2, pp.239-245, 2011. ,
DOI : 10.1373/clinchem.2006.084509
Circulating cell-free DNA: A novel biomarker for response to therapy in ovarian carcinoma, Cancer Biology & Therapy, vol.5, issue.10, pp.1369-1374, 2006. ,
DOI : 10.4161/cbt.5.10.3240
URL : http://www.tandfonline.com/doi/pdf/10.4161/cbt.5.10.3240?needAccess=true
Serial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA, Cancer Research, vol.67, issue.19, pp.9364-9370, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-0605
Cell-free nucleic acids as biomarkers in cancer patients, Nature Reviews Cancer, vol.61, issue.83, pp.426-437, 2011. ,
DOI : 10.3322/caac.20107
Amount of DNA in plasma and cancer risk: A prospective study, International Journal of Cancer, vol.84, issue.5, pp.746-749, 2004. ,
DOI : 10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.0.CO;2-J
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer, Cancer Letters, vol.263, issue.2, pp.170-181, 2008. ,
DOI : 10.1016/j.canlet.2008.03.021
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing, Science Translational Medicine, vol.14, issue.9, pp.20-34, 2010. ,
DOI : 10.1038/nm.1789
URL : http://stm.sciencemag.org/content/scitransmed/2/20/20ra14.full.pdf
Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proceedings of the National Academy of Sciences, vol.315, issue.1-2, pp.16368-16373, 2005. ,
DOI : 10.1016/S0009-8981(01)00712-4
Circulating mutant DNA to assess tumor dynamics, Nature Medicine, vol.3, issue.9, pp.985-990, 2008. ,
DOI : 10.1136/jmg.36.10.730
URL : http://europepmc.org/articles/pmc2820391?pdf=render
Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients, Gastroenterology, vol.135, issue.2, pp.489-498, 2008. ,
DOI : 10.1053/j.gastro.2008.05.039
Analysis of Circulating Tumor DNA to Confirm Somatic KRAS Mutations, JNCI: Journal of the National Cancer Institute, vol.99, issue.3, pp.1284-1285, 2009. ,
DOI : 10.1038/sj.bjc.6604451
URL : https://academic.oup.com/jnci/article-pdf/101/18/1284/18614269/djp240.pdf
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Research, vol.70, issue.18, pp.6159-6175, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-3513
URL : https://academic.oup.com/nar/article-pdf/38/18/6159/18784440/gkq421.pdf
High fragmentation characterizes tumourderived circulating DNA, PLoS One, vol.6, 2011. ,
DOI : 10.1371/journal.pone.0023418
URL : https://doi.org/10.1371/journal.pone.0023418
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments, Clinical Chemistry, vol.55, issue.4, pp.611-622, 2009. ,
DOI : 10.1373/clinchem.2008.112797
URL : http://clinchem.aaccjnls.org/content/clinchem/55/4/611.full.pdf
Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method, PLoS ONE, vol.26, issue.2, p.4584, 2009. ,
DOI : 10.1371/journal.pone.0004584.s003
URL : https://doi.org/10.1371/journal.pone.0004584
KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?, British Journal of Cancer, vol.102, issue.6, pp.1074-1075, 2010. ,
DOI : 10.1373/49.6.853
URL : http://www.nature.com/bjc/journal/v102/n6/pdf/6605582a.pdf
A blood-based DNA test for colorectal cancer screening, Discov Med, vol.7, pp.7-12, 2007. ,
Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells, PLoS ONE, vol.1, issue.10, p.7464, 2009. ,
DOI : 10.1371/journal.pone.0007464.s011
URL : https://doi.org/10.1371/journal.pone.0007464
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells, Immunology, vol.273, issue.1, pp.55-62, 2005. ,
DOI : 10.1002/art.20254
Growth kinetics of human colorectal carcinoma, Cancer Res, vol.45, pp.2128-2131, 1985. ,
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients, British Journal of Cancer, vol.26, issue.10, pp.1519-1523, 2010. ,
DOI : 10.1016/j.humpath.2007.04.008
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res, vol.61, pp.1659-1665, 2001. ,
Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma, Experimental and Molecular Pathology, vol.80, issue.1, pp.72-76, 2006. ,
DOI : 10.1016/j.yexmp.2005.05.001
The virtosome-a novel cytosolic informative entity and intercellular messenger, Cell Biochemistry and Function, vol.95, issue.9, pp.529-538, 2010. ,
DOI : 10.3109/08820137309022799
Cell-free DNA in the blood as a solid tumor biomarker???A critical appraisal of the literature, Clinica Chimica Acta, vol.411, issue.21-22, pp.1611-1624, 2010. ,
DOI : 10.1016/j.cca.2010.07.032
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer, The Journal of Urology, vol.181, issue.1, pp.363-371, 2009. ,
DOI : 10.1016/j.juro.2008.08.118